Adicet Operating Margin from 2010 to 2024

ACET Stock  USD 1.73  0.04  2.37%   
Adicet Bio Operating Profit Margin yearly trend continues to be comparatively stable with very little volatility. Operating Profit Margin will likely drop to -3.51 in 2024.
Check Adicet Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adicet main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 M, Selling General Administrative of 34.7 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 13.27, Dividend Yield of 0.0 or PTB Ratio of 0.45. Adicet financial statements analysis is a perfect complement when working with Adicet Bio Valuation or Volatility modules.
  
This module can also supplement Adicet Bio's financial leverage analysis and stock options assessment as well as various Adicet Bio Technical models . Check out the analysis of Adicet Bio Correlation against competitors.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Latest Adicet Bio's Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of Adicet Bio over the last few years. It is Adicet Bio's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adicet Bio's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.00 %10 Years Trend
Slightly volatile
   Operating Profit Margin   
       Timeline  

Adicet Operating Margin Regression Statistics

Arithmetic Mean(3.54)
Geometric Mean0.28
Coefficient Of Variation(225.01)
Mean Deviation4.10
Median(1.83)
Standard Deviation7.97
Sample Variance63.58
Range31.6325
R-Value(0.32)
Mean Square Error61.65
R-Squared0.1
Significance0.25
Slope(0.56)
Total Sum of Squares890.06

Adicet Operating Margin History

2024 -3.51
2023 -3.34
2022 -2.9
2021 -6.31
2020 -2.19
2019 -31.55

About Adicet Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Adicet Bio income statement, its balance sheet, and the statement of cash flows. Adicet Bio investors use historical funamental indicators, such as Adicet Bio's Operating Margin, to determine how well the company is positioned to perform in the future. Although Adicet Bio investors may use each financial statement separately, they are all related. The changes in Adicet Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Adicet Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Adicet Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Adicet Bio. Please read more on our technical analysis and fundamental analysis pages.
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 86 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adicet Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adicet Bio's short interest history, or implied volatility extrapolated from Adicet Bio options trading.

Pair Trading with Adicet Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adicet Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adicet Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Adicet Stock

  0.62CVS CVS Health CorpPairCorr
  0.84FNA Paragon 28PairCorr
  0.65MDT Medtronic PLC Financial Report 23rd of May 2024 PairCorr

Moving against Adicet Stock

  0.82ELMD ElectromedPairCorr
  0.55INSP Inspire Medical SystemsPairCorr
  0.47NNOX Nano X ImagingLtd Financial Report 27th of May 2024 PairCorr
The ability to find closely correlated positions to Adicet Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adicet Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adicet Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adicet Bio to buy it.
The correlation of Adicet Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adicet Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adicet Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adicet Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Adicet Bio is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Adicet Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Adicet Bio Stock. Highlighted below are key reports to facilitate an investment decision about Adicet Bio Stock:
Check out the analysis of Adicet Bio Correlation against competitors.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.
Note that the Adicet Bio information on this page should be used as a complementary analysis to other Adicet Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Adicet Stock analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
CEOs Directory
Screen CEOs from public companies around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Is Adicet Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.31)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.31)
Return On Equity
(0.62)
The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adicet Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.